BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Est. Return 36.47%
This Quarter Est. Return
1 Year Est. Return
+36.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$971M
AUM Growth
+$171M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$25.8M
2
+$25.8M
3
+$25.6M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$7.29M
5
ANNX icon
Annexon
ANNX
+$2.87M

Top Sells

1
+$29.2M
2
+$19.8M
3
+$19.4M
4
TVRD
Tvardi Therapeutics
TVRD
+$3.59M
5
SYRE icon
Spyre Therapeutics
SYRE
+$1.55M

Sector Composition

1 Healthcare 98.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$6.69M 0.69%
2,124,694
27
$6.38M 0.66%
1,921,790
28
$4.52M 0.47%
1,642,210
29
$3.08M 0.32%
640,631
30
$2.65M 0.27%
25,969
-35,266
31
$2.03M 0.21%
1,937,207
32
$209K 0.02%
100,000
33
– –
-213,908
34
– –
-8,891,758
35
– –
-4,702,996
1
2